密集递表！11月15家医药企业拟赴港上市，5家带特殊标识“B”

Group 1 - The trend of pharmaceutical companies applying for listings in Hong Kong continues, with 15 companies submitting applications in November alone, following a busy October [1] - Distinct Healthcare Holdings Limited was the first pharmaceutical company to submit an application in November, while Olin Biologicals, which is already listed on A-shares, was the latest to apply on November 25 [1] - Notably, five of the companies applying for listings are unprofitable biotech firms, which have been allowed to list in Hong Kong since the implementation of the new Chapter 18A in April 2018 [3] Group 2 - The A+H listing trend is also ongoing, with several A-share listed companies, including Kexing Pharmaceutical and Olin Biologicals, submitting applications to the Hong Kong Stock Exchange [4] - Olin Biologicals announced on November 26 that it submitted an application for a public offering of H-shares on November 25, with a debt ratio of 50.21% and cash balance of 170 million yuan as of the end of Q3 [4] - The growth of the biotech and innovative drug sectors has increased market interest, with Hong Kong being positioned as a significant opportunity for pharmaceutical companies seeking global funding [4]